351 related articles for article (PubMed ID: 24031028)
1. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
3. 17β-Estradiol positively modulates growth hormone signaling through the reduction of SOCS2 negative feedback in human osteoblasts.
Bolamperti S; Mrak E; Moro G; Sirtori P; Fraschini G; Guidobono F; Rubinacci A; Villa I
Bone; 2013 Jul; 55(1):84-92. PubMed ID: 23567159
[TBL] [Abstract][Full Text] [Related]
4. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ
J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564
[TBL] [Abstract][Full Text] [Related]
5. Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice.
Michaylira CZ; Ramocki NM; Simmons JG; Tanner CK; McNaughton KK; Woosley JT; Greenhalgh CJ; Lund PK
Endocrinology; 2006 Apr; 147(4):1632-41. PubMed ID: 16410303
[TBL] [Abstract][Full Text] [Related]
6. SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.
Hoefer J; Kern J; Ofer P; Eder IE; Schäfer G; Dietrich D; Kristiansen G; Geley S; Rainer J; Gunsilius E; Klocker H; Culig Z; Puhr M
Endocr Relat Cancer; 2014 Apr; 21(2):175-87. PubMed ID: 24280133
[TBL] [Abstract][Full Text] [Related]
7. Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo.
Michaylira CZ; Simmons JG; Ramocki NM; Scull BP; McNaughton KK; Fuller CR; Lund PK
Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G472-81. PubMed ID: 16574995
[TBL] [Abstract][Full Text] [Related]
8. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
9. Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells.
Recouvreux MV; Wu JB; Gao AC; Zonis S; Chesnokova V; Bhowmick N; Chung LW; Melmed S
Endocrinology; 2017 Jul; 158(7):2255-2268. PubMed ID: 28444169
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
[TBL] [Abstract][Full Text] [Related]
11. Human prostate cancer xenografts in lit/lit mice exhibit reduced growth and androgen-independent progression.
Takahara K; Tearle H; Ghaffari M; Gleave ME; Pollak M; Cox ME
Prostate; 2011 Apr; 71(5):525-37. PubMed ID: 20878948
[TBL] [Abstract][Full Text] [Related]
12. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.
Miyake H; Pollak M; Gleave ME
Cancer Res; 2000 Jun; 60(11):3058-64. PubMed ID: 10850457
[TBL] [Abstract][Full Text] [Related]
13. Regulation of growth hormone receptors in human prostate cancer cell lines.
Bidosee M; Karry R; Weiss-Messer E; Barkey RJ
Mol Cell Endocrinol; 2009 Oct; 309(1-2):82-92. PubMed ID: 19540305
[TBL] [Abstract][Full Text] [Related]
14. Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model.
Krueckl SL; Sikes RA; Edlund NM; Bell RH; Hurtado-Coll A; Fazli L; Gleave ME; Cox ME
Cancer Res; 2004 Dec; 64(23):8620-9. PubMed ID: 15574769
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone affects gene expression and proliferation in human prostate cancer cells.
Bidosee M; Karry R; Weiss-Messer E; Barkey RJ
Int J Androl; 2011 Apr; 34(2):124-37. PubMed ID: 20546049
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer.
Hara N; Takizawa I; Isahaya E; Nishiyama T; Hoshii T; Ishizaki F; Takahashi K
Urol Oncol; 2012 Sep; 30(5):596-601. PubMed ID: 21458314
[TBL] [Abstract][Full Text] [Related]
17. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding.
Chen Y; Sun D; Krishnamurthy VM; Rabkin R
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1856-62. PubMed ID: 17327369
[TBL] [Abstract][Full Text] [Related]
18. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M
Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404
[TBL] [Abstract][Full Text] [Related]
19. A designed cell-penetrating human SOCS2 protein suppresses GH-dependent cancer cell proliferation.
Miyamoto A; Masuhiro Y; Seki T; Hanazawa S; Shiba H
Biosci Biotechnol Biochem; 2019 Feb; 83(2):300-308. PubMed ID: 30343638
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer.
Shiota M; Yokomizo A; Naito S
Free Radic Biol Med; 2011 Oct; 51(7):1320-8. PubMed ID: 21820046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
